×

Cramer: Gilead crux of health care in US

9:08 AM ET Wed, 23 April 2014

Record sales of a new hepatitis C drug pushed the first-quarter earnings of Gilead Sciences beyond expectations. The "Squawk on the Street" news team break down its quarterly beat.